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ng, and interventions to prevent perinatal transmission of HIV, at
SS Hospital, Mysore.
Methods: All women attending antenatal clinics of the hos-
ital from October 2002 to December 2010 were counseled and
ubjected to HIV testing after an informed consent. Those found
ositive, were conﬁrmed to be seropositive, by two more rapid
ests. Such women were given SDNVP (200mg) at the onset of
abour.Ceasarian delivery was carried out with universal precau-
ions. Neonate was administered SDNVP (2mg/kg body weight)
t birth. Exclusive breast feeding was advised, baby followed up.
ested at 18 months of age by rapid tests for HIV.
Results: Out of 21003 women tested, 71 were conﬁrmed posi-
ive. 46 (65%) patients delivered in our hospital. 30 patients were
ollowed up for up to 18 months. None of these babies were
eropositive at 18 months.
Conclusion: The intervention in PPTCT to signiﬁcantly reduce
erinatal transmission of HIV can be successful if guidelines are
ollowed strictly and if the services are integrated with Maternal
nd Child Health services of the hospitals.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.748
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oles of mixing of drug-use network and sexual network on
eterosexual transmission of HIV among young drug users: an
gocentric network study in Yunnan, China
. Liu1,∗, J. Li 2, J. Li 1
Virginia Commonwealth University, Richmond, VA, USA
Yunnan Institute for Drug Abuse, Kunming, China
Background: The heterosexually transmitted HIV infection rate
s rapidly increasing among young drug users in China. HIV trans-
ission may be inﬂuenced by mixing of drug-use network and
exual network characteristics.
Methods: A community-based survey was conducted in Yun-
an, China, in which respondent-driving sampling (RDS) was used
o sample heroin users who were 18-35 years old. Using an ego-
entric social network questionnaire, we deﬁned two types of
etworks: drug use network and sexual network. Respondents
ere deﬁned as having mixing networks if they reported having
ad both a sexual network and a drug-use network.
Results: Among 426 respondents, 242 reported having had
ixing of both sexual network and drug-use network. The RDS-
djusted proportion of respondents having mixing networks was
6%. Among those who had mixing networks, 26% reported hav-
ng had both injection drug using (IDU) peers and non-injection
rug using (NIDU) peers, and 32% having had both regular and
on-regular sexual partners in their networks. Compared to those
ithout mixing networks, respondents with mixing were more
ikely to engage in risks forHIV infection. Speciﬁcally,more respon-
ents with mixing networks than those without reported having
ad (1) 2-3 sexual partners (31% vs. 20%), (2) both regular and
on-regular sexual partners (26% vs. 21%), (3) concurrent sexual
artnerships (52% vs. 40%), (4) IDU network peers (79% vs. 30%),
nd (6) NIDU peers in their network (48% vs. 33%). Consistent con-
om use with regular or non-regular partners was low in the two
roups, between 18% and 46%. The risk of parenteral transmissionfectious Diseases 16S (2012) e158–e316
of HIV was relatively low. Measured over life time, only about 2%
of drug users with or without mixing networks shared needles for
half or more episodes of injecting. Over the last 30 days, only 8% of
drug users with mixing networks and 4% of those without had ever
sheared them with others.
Conclusion: The ﬁndings of this study document that het-
erosexual HIV transmission can be driven by mixing patterns of
drug-use network and sexual network and the generalization of
the HIV epidemic from high-risk groups to the general population.
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Factors inﬂuencing the initiation of antiretroviral therapy in
HIV infected patients attending the Bamenda and the Bertoua
regional treatment centers in Cameroon
F.-X.Mbopi-Keou1,∗, E. Voundi Voundi2, I. Emah3, F. Angwafo III 1,
W. Muna1
1 Ministry of Health & University of Yaounde I, Yaounde, Cameroon
2 Ministry of Health, Bertoua, Cameroon
3 Ministry of Health, Yaounde, Cameroon
Background: In sub-Saharan Africa, access to antiretroviral
drugs (ARVs) remains low due to various obstacles. Encouraging
progress in the availability of these drugs in Cameroon has been
noted leading to an increase number of treatment centers and an
increase number of patients under ARVs. The present study aimed
at determining the factors inﬂuencing the initiation of ARV therapy
in HIV infected patients attending the Bamenda and the Bertoua
regional treatment centers in Cameroon (RTC).
Methods: A cross sectional study involving 460 ﬁles of HIV
infected adult patients attending the Bamenda and the Bertoua RTC
was carried out from January to April 2011. Socio-demographic,
biological and clinical characteristics including the antiretroviral
treatment were compared between these RTC. Data were analysed
using the Chi-Squared and the Ficher, and statistical signiﬁcance
was set at p <0.05.
Results: Out of the 460 ﬁles, 53.9% were from Bamenda and
46.1% from Bertoua RTC. The median age of patients was 36 years
in Bamenda and 35 years in Bertoua. There were more female
patients in both the Bamenda (69, 0%) and the Bertoua (61, 8%)
RTC (p=0.11). The majority of patients in Bertoua discovered their
HIV status through voluntary testing as compared to those in
Bamenda (41 vs 22; p=0.008). HIV type 1 and 2 viruses were
more frequent in Bamenda than in Bertoua (15 vs 3; p=0.011).
The median CD4 count was 133 cells/mm3 in Bamenda and 175
cell/mm3 in Bertoua (p=0.008). Standard ﬁrst line ARV drugs were
the most used protocols [Bamenda (93.1%) and Bertoua (98.1)].
Zidovudine, Nevirapine and Lopinavir were more frequently used
in Bamenda (p=0.000), while Tenofovir and Effavirenz were more
used in Bertoua (p=0.017).Conclusion: This study highlights the fact that socio-
demographic, biological and clinical management of patients differ
from one RTC to the other in Cameroon, even when both have a
high HIV prevalence. We therefore recommend the standardiza-
